In Vitro Diagnostics Market Research Reports & Industry Analysis
In Vitro Diagnostics Industry Research & Market Reports
-
In-Vitro Colorectal Cancer Screening Tests
... is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Fecal Occult Blood Test, one of the segments analyzed in the report, is expected to record ... Read More
-
Human Papillomavirus (HPV) Testing
... reach US$1.8 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR ... Read More
-
Specimen Validity Testing
... by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Specimen Validity Testing Products, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$2.9 ... Read More
-
Helicobacter Pylori Diagnostics
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$436.9 Million by ... Read More
-
Clinical Risk Grouping Solutions
... 2030, growing at a CAGR of 13.7% over the analysis period 2023-2030. Scorecard & Visualization Tools, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$1.1 Billion ... Read More
-
Toxicology Testing Services
... at a CAGR of 8.4% over the analysis period 2023-2030. In Vivo Method, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$10.2 Billion by the end ... Read More
-
In Vitro Diagnostics (IVD) Quality Control
... reach US$1.8 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Clinical Chemistry Application, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and ... Read More
-
Infectious Disease Point-of-care (POC) Diagnostics Market
... now projected to grow from USD 15.21 billion in 2024 to USD 12.46 billion by 2032, exhibiting a CAGR of -2.8% during the forecast period of 2024-2032. In the havoc of the widespread the Infectious ... Read More
-
Multiplex Assays
... at a CAGR of 6.4% over the analysis period 2023-2030. Protein Assays, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$2.5 Billion by the end of ... Read More
-
Mycotoxin Testing
... at a CAGR of 5.9% over the analysis period 2023-2030. Spectroscopy- & Chromatography-Based Testing, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$1.6 Billion by the ... Read More
-
Mycoplasma Testing
... at a CAGR of 8.5% over the analysis period 2023-2030. Mycoplasma Testing Assays, Kits & Reagents, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$940.8 Million ... Read More
-
Immunoprotein Diagnostic Testing
... by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Immunoglobulin Diagnostic, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$6.4 Billion by ... Read More
-
Hepatitis Therapeutics
... at a CAGR of 3.7% over the analysis period 2023-2030. Hepatitis C Disease Type, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$17.8 Billion by the ... Read More
-
Paper Diagnostics
... at a CAGR of 6.6% over the analysis period 2023-2030. Lateral Flow Assay Kits, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$6.7 Billion by the ... Read More
-
Heparin
... of 2.8% over the analysis period 2023-2030. Low Molecular Weight Heparin (LMWH), one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$5.9 Billion by the end of ... Read More
-
Herpes Marker Testing
... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$279.9 Million ... Read More
-
Multiplex Detection Immunoassays
... by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Disease Testing Application, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.5 Billion ... Read More
-
Nucleic Acid Labeling
... by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Nucleic Acid Labeling Reagents, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.4 ... Read More
-
Oxidative Stress Assays
... by 2030, growing at a CAGR of 8.5% over the analysis period 2023-2030. ELISA Technology, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$673.6 Million by ... Read More
-
Coagulation / Hemostasis Analyzers
... reach US$5.0 Billion by 2030, growing at a CAGR of 3.0% over the analysis period 2023-2030. Clinical Laboratory Analyzers, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and ... Read More
-
Glucose Biosensors
... at a CAGR of 2.1% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 1.8% CAGR and reach US$1.5 Billion by the end of ... Read More
-
The Global Microfluidics Market 2025-2035
... to revolutionize traditional approaches to diagnostics, drug development, and process control. Medical applications currently dominate market share, with point-of-care diagnostics and pharmaceutical research leading growth, while industrial applications in environmental monitoring, food safety, and process ... Read More
-
Vietnam Clinical Laboratories Market Outlook to 2028
... Tests in Vietnam, growth in non-communicable diseases and chronic diseases, Increasing focus on preventive medicine, and Technological Advancements. The market is dominated by key players such as Dai Hoc Y Duoc Hospital, Thong Nhat Hospital ... Read More
-
Testing and Analysis Services
... 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Elemental Analysis, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$12.4 Billion by the ... Read More
-
Veterinary Hematology Analyzers
... at a CAGR of 5.3% over the analysis period 2023-2030. Table Top Analyzers, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.2 Billion by the end ... Read More
Research Assistance
